Long-term treatment data for lecanemab to be presented at AAIC 2024 ...Middle East

STOCKHOLM , July 23, 2024 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today announced that its partner Eisai will present the latest findings on lecanemab (generic name, brand name Leqembi®) at the Alzheimer's Association International Conference (AAIC) 2024. The...

Hence then, the article about long term treatment data for lecanemab to be presented at aaic 2024 was published today ( Tuesday 23/07/2024 - 09:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Long-term treatment data for lecanemab to be presented at AAIC 2024 )

Also on site :

• Johnny Knoxville Takes Credit For “Monstrous Explosion” In Simi Valley During ‘Jackass: Best and Last’ Wrap
• UAE in talks with U.S. for possible financial lifeline, WSJ says
• ‘Facts of Life’ Icon Showered with Love and Prayers After Revealing Cancer Battle